Whitegate Investment Counselors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,794
Closed -$397K 215
2021
Q3
$397K Hold
2,794
0.06% 174
2021
Q2
$436K Buy
2,794
+15
+0.5% +$2.43K 0.06% 168
2021
Q1
$432K Hold
2,779
0.07% 163
2020
Q4
$416K Sell
2,779
-402
-13% -$56.8K 0.07% 162
2020
Q3
$420K Buy
3,181
+103
+3% +$13.5K 0.08% 151
2020
Q2
$357K Buy
3,078
+387
+14% +$44.6K 0.07% 152
2020
Q1
$264K Sell
2,691
-1,571
-37% -$206K 0.06% 155
2019
Q4
$619K Buy
4,262
+118
+3% +$16.3K 0.11% 136
2019
Q3
$552K Buy
4,144
+129
+3% +$16.7K 0.11% 136
2019
Q2
$459K Buy
4,015
+809
+25% +$94.8K 0.09% 137
2019
Q1
$398K Sell
3,206
-5,588
-64% -$635K 0.08% 142
2018
Q4
$886K Sell
8,794
-927
-10% -$104K 0.2% 99
2018
Q3
$1.24M Buy
9,721
+57
+0.6% +$6.78K 0.25% 93
2018
Q2
$1.05M Buy
9,664
+242
+3% +$26.3K 0.21% 98
2018
Q1
$997K Buy
+9,422
New +$1.09M 0.21% 103

Other funds holding ZBH

Whitegate Investment Counselors's ZBH Position: Q4 2021 in Review

Whitegate Investment Counselors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 2,794 shares — an estimated $397K sold.

Whitegate Investment Counselors first reported a position in ZBH in Q1 2018 and held it in 15 quarters. The position peaked at $1.24M in Q3 2018. 999 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Whitegate Investment Counselors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Whitegate Investment Counselors sold 2,794 Zimmer Biomet shares in Q4 2021, an estimated $397K.
  • Whitegate Investment Counselors first reported a position in Zimmer Biomet in Q1 2018 and held it in 15 quarters.
  • Whitegate Investment Counselors's Zimmer Biomet position peaked at $1.24M in Q3 2018.
  • 999 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.